CombiMatrix Launches Deal with NASA | GenomeWeb

NEW YORK, Aug. 8 – CombiMatrix will see its microarrays launched into space in a deal with NASA Ames Research Center, the company announced on Wednesday.

The National Aeronautics and Space Administration has agreed to license and purchase CombiMatrix’s active biochips and technology to use in biological research in ground-based labs and aboard the International Space Station. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.